Mikhail Eydelman

Insider Reports History

Location
San Carlos, CA
Signature
Mikhail Eydelman, by /s/ Peter N. Efremenko, Attorney-In-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Mikhail Eydelman:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Vaxcyte, Inc. SVP, GEN COUNSEL & CORP SEC Common Stock 41.6K $3.01M $72.37 05 Mar 2025 Direct
Vaxcyte, Inc. SVP, GEN COUNSEL & CORP SEC Stock Option (right to buy) 144K 05 Mar 2025 Direct
Vaxcyte, Inc. SVP, GEN COUNSEL & CORP SEC Performance Stock Option (right to buy) 26.1K 07 Nov 2024 Direct

Insider Reports Filed by Mikhail Eydelman

Symbol Company Period Transactions Value $ Form Type Role Filing Time
PCVX Vaxcyte, Inc. 05 Mar 2025 5 -$247K 4 SVP, GEN COUNSEL & CORP SEC 07 Mar 2025, 16:43
PCVX Vaxcyte, Inc. 27 Feb 2025 4 -$78.7K 4 SVP, GEN COUNSEL & CORP SEC 03 Mar 2025, 21:15
PCVX Vaxcyte, Inc. 05 Feb 2025 7 -$343K 4 SVP, GEN COUNSEL & CORP SEC 07 Feb 2025, 16:04
PCVX Vaxcyte, Inc. 06 Jan 2025 5 -$321K 4 SVP, GEN COUNSEL & CORP SEC 07 Jan 2025, 16:33
PCVX Vaxcyte, Inc. 05 Dec 2024 7 -$394K 4 SVP, GEN COUNSEL & CORP SEC 09 Dec 2024, 18:28
PCVX Vaxcyte, Inc. 07 Nov 2024 1 $0 4 SVP, GEN COUNSEL & CORP SEC 08 Nov 2024, 20:50
PCVX Vaxcyte, Inc. 05 Nov 2024 6 -$425K 4 SVP, GEN COUNSEL & CORP SEC 06 Nov 2024, 16:15
PCVX Vaxcyte, Inc. 07 Oct 2024 7 -$439K 4 SVP, GEN COUNSEL & CORP SEC 08 Oct 2024, 20:29
PCVX Vaxcyte, Inc. 01 Oct 2024 5 -$511K 4 SVP, GEN COUNSEL & CORP SEC 03 Oct 2024, 16:15
PCVX Vaxcyte, Inc. 03 Sep 2024 10 -$394K 4 SVP, GEN COUNSEL & CORP SEC 05 Sep 2024, 17:13
PCVX Vaxcyte, Inc. 01 Aug 2024 4 -$95.8K 4 SVP, GEN COUNSEL & CORP SEC 05 Aug 2024, 16:06
PCVX Vaxcyte, Inc. 01 Jul 2024 4 -$91.6K 4 SVP, GEN COUNSEL & CORP SEC 02 Jul 2024, 16:17
PCVX Vaxcyte, Inc. 07 Jun 2024 1 -$23.8K 4 SVP, GEN COUNSEL & CORP SEC 10 Jun 2024, 16:13
PCVX Vaxcyte, Inc. 03 Jun 2024 5 -$84.4K 4 SVP, GEN COUNSEL & CORP SEC 05 Jun 2024, 16:58
PCVX Vaxcyte, Inc. 01 May 2024 5 -$67.2K 4 SVP, GEN COUNSEL & CORP SEC 03 May 2024, 16:20
PCVX Vaxcyte, Inc. 01 Apr 2024 4 -$75.5K 4 SVP, GEN COUNSEL & CORP SEC 03 Apr 2024, 16:22
PCVX Vaxcyte, Inc. 29 Feb 2024 8 -$131K 4 SVP, GEN COUNSEL & CORP SEC 04 Mar 2024, 21:21
PCVX Vaxcyte, Inc. 01 Feb 2024 6 -$87.5K 4 SVP, GEN COUNSEL & CORP SEC 05 Feb 2024, 17:39
PCVX Vaxcyte, Inc. 02 Jan 2024 5 -$70.9K 4 SVP, Gen Counsel & Corp Sec 04 Jan 2024, 16:26
PCVX Vaxcyte, Inc. 07 Dec 2023 4 -$369K 4 SVP, Gen Counsel & Corp Sec 11 Dec 2023, 16:36
PCVX Vaxcyte, Inc. 02 Oct 2023 5 -$580K 4 SVP, Gen Counsel & Corp Sec 04 Oct 2023, 16:07
PCVX Vaxcyte, Inc. 05 Sep 2023 1 -$60.6K 4 SVP, Gen Counsel & Corp Sec 06 Sep 2023, 18:35
PCVX Vaxcyte, Inc. 07 Jun 2023 1 -$33.1K 4 SVP, Gen Counsel & Corp Sec 09 Jun 2023, 16:24
PCVX Vaxcyte, Inc. 01 Mar 2023 2 $0 4 SVP, Gen Counsel & Corp Sec 03 Mar 2023, 16:11
PCVX Vaxcyte, Inc. 30 Dec 2022 1 $0 4 SVP, Gen Counsel & Corp Sec 04 Jan 2023, 15:31
PCVX Vaxcyte, Inc. 07 Jun 2022 1 $0 4 SVP, Gen Counsel & Corp Sec 09 Jun 2022, 16:43
PCVX Vaxcyte, Inc. 09 May 2022 1 $0 4 SVP, Gen Counsel & Corp Sec 11 May 2022, 17:11
PCVX Vaxcyte, Inc. 01 Apr 2022 0 $0 3 SVP, Gen Counsel & Corp Sec 11 Apr 2022, 16:49